AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Scope & Guideline
Exploring the frontiers of pulmonary medicine and patient care.
Introduction
Aims and Scopes
- Respiratory Diseases:
The journal addresses a wide range of respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, and pulmonary hypertension, emphasizing both clinical and molecular research. - Critical Care Medicine:
The focus extends to critical care medicine, particularly the management of patients with acute respiratory distress syndrome (ARDS), sepsis, and other critical conditions, highlighting advancements in intensive care practices. - Molecular and Cellular Biology:
Research published in the journal often explores the underlying molecular and cellular mechanisms of lung diseases, including studies on gene expression, inflammation, and immune response. - Innovative Therapeutic Approaches:
The journal features studies on novel therapeutic strategies, including pharmacological interventions, biologics, and emerging therapies for various pulmonary conditions. - Public Health and Epidemiology:
The journal also emphasizes public health issues related to respiratory diseases, including studies on the impact of environmental factors, tobacco use, and healthcare disparities. - Patient-Centered Research:
There is a strong focus on patient-reported outcomes and quality of life, aiming to integrate patient perspectives into research and clinical care.
Trending and Emerging
- Personalized Medicine:
Emerging research focuses on tailoring treatments based on genetic, environmental, and lifestyle factors, particularly in conditions like asthma and pulmonary fibrosis, emphasizing the importance of individualized patient care. - Telemedicine and Remote Monitoring:
The COVID-19 pandemic has accelerated the adoption of telemedicine and remote patient monitoring technologies, leading to an increase in studies evaluating their effectiveness in managing chronic respiratory diseases. - Long-COVID and Post-Acute Sequelae:
There is growing attention on the long-term effects of COVID-19, including post-acute sequelae, with research exploring respiratory, cardiovascular, and neurological implications, highlighting the need for comprehensive care strategies. - Microbiome Research:
Increasing interest in the role of the lung microbiome in health and disease, particularly its impact on asthma, COPD, and pulmonary infections, is emerging as a significant area of research. - Innovations in Imaging Techniques:
Advancements in imaging technologies, such as machine learning applications in radiology and novel imaging biomarkers, are gaining prominence for their potential to enhance diagnosis and monitoring of lung diseases. - Environmental and Social Determinants of Health:
Research increasingly emphasizes the impact of environmental factors and social determinants on respiratory health, focusing on disparities and the need for community-based interventions.
Declining or Waning
- Traditional Diagnostic Methods:
There appears to be a decreasing emphasis on traditional diagnostic methods, such as bronchoscopies and lung biopsies, as newer, less invasive techniques and imaging modalities gain traction. - Basic Science without Clinical Correlation:
Research focusing solely on basic science without direct clinical implications or applications is becoming less prevalent, as there is a greater push for translational research that bridges laboratory findings to patient care. - General Pulmonary Rehabilitation:
While pulmonary rehabilitation remains important, there is a shift towards more specialized and targeted rehabilitation practices rather than general approaches, leading to a decline in studies focusing on broad rehabilitation protocols. - Conventional Pharmaceutical Approaches:
There is a noticeable reduction in studies promoting conventional pharmaceutical approaches, with more research being directed towards personalized medicine and biologic therapies. - Single Disease Focus:
Research that concentrates on single diseases, such as isolated studies on asthma or COPD without considering comorbidities, appears to be waning in favor of studies that examine the interplay between multiple conditions.
Similar Journals
Pulmonary Medicine
Championing Open Access for Global Health SolutionsPulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.
CHEST
Advancing knowledge in cardiology and critical care.CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.
Zeitschrift fur Pneumologie
Advancing Lung Health Through Innovative ResearchZeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.
Egyptian Journal of Chest Diseases and Tuberculosis
Championing research that breathes life into pulmonary health.The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.
Tuberkuloz ve Toraks-Tuberculosis and Thorax
Innovating the future of tuberculosis care.Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.
RESPIROLOGY
Unveiling Breakthroughs in Respiratory HealthRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
Pulmonology
Leading the way in open-access research for respiratory disorders.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.
Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine
Unlocking Vital Research in Circulatory and Respiratory MedicineClinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.
Annals of the American Thoracic Society
Connecting researchers and clinicians for a healthier tomorrow.Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.
Journal of Critical & Intensive Care
Exploring the complexities of critical care medicine.The Journal of Critical & Intensive Care, published by the esteemed Soc Turkish Intensivists - STI, serves as a vital platform for advancing knowledge and research in the evolving fields of critical care and intensive medicine. Since its inception in 2020, this journal has focused on disseminating high-quality research that addresses the complexities and challenges faced in the intensive care units, positioning itself as a critical resource for healthcare professionals, researchers, and students in Turkey and beyond. Although currently categorized in the Q4 quartile for Critical Care and Intensive Care Medicine, with a Scopus rank of 99 out of 110, the journal is rapidly gaining attention for its scholarly contributions. With an ongoing commitment to open access principles, it aims to enhance accessibility to groundbreaking studies and reviews, promoting collaborative progress in the critical care domain. The Journal of Critical & Intensive Care is not just a publication; it is a catalyst for innovation and knowledge-sharing critical to improving patient outcomes in intensive care settings.